Figure 4.

Levels of secreted SPARC increased during IM therapy. Secreted protein was evaluated by ELISA in CML 10 patients at D, 6 of which followed during TKI therapy. Data are expressed as means ± S.D.

Giallongo et al. BMC Cancer 2013 13:60   doi:10.1186/1471-2407-13-60
Download authors' original image